tiprankstipranks
Trending News
More News >
Dentalcorp Holdings Ltd. (TSE:DNTL)
:DNTL
Canadian Market
Advertisement

dentalcorp Holdings (DNTL) AI Stock Analysis

Compare
120 Followers

Top Page

TSE:DNTL

dentalcorp Holdings

(TSX:DNTL)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
C$8.50
▼(-21.73% Downside)
dentalcorp Holdings shows positive revenue growth and solid cash flow, which are strong indicators for future performance. However, the company's profitability issues and negative P/E ratio weigh down its overall score. Technical analysis suggests a neutral to slightly positive market sentiment, but valuation concerns remain significant.
Positive Factors
Revenue Growth
Steady revenue growth indicates expanding market presence and effective business model execution, supporting long-term financial health.
Cash Flow Position
Positive cash flow growth demonstrates strong operational efficiency, enabling reinvestment in growth initiatives and debt management.
Operational Efficiency
A strong gross profit margin highlights effective cost control, which can support profitability improvements and competitive positioning.
Negative Factors
Profitability Challenges
Persistent profitability issues can hinder long-term growth and shareholder returns, necessitating strategic focus on cost and revenue optimization.
Negative Return on Equity
Negative ROE indicates inefficiencies in capital use, potentially impacting investor confidence and future capital raising capabilities.
Net Profit Margin
A negative net profit margin suggests that revenue growth is not translating into profits, which could affect long-term sustainability and investment appeal.

dentalcorp Holdings (DNTL) vs. iShares MSCI Canada ETF (EWC)

dentalcorp Holdings Business Overview & Revenue Model

Company Descriptiondentalcorp Holdings Ltd., through its subsidiaries, acquires and partners with dental practices to provide health care services in Canada. As of December 31, 2021, it owned and operated a network of approximately 458 dental practices supported by approximately 7,400 team members, including 1,400 dentists, 1,700 hygienists, and 4,100 auxiliary dental health professionals. The company was formerly known as Dentalcorp Overbite Ltd. dentalcorp Holdings Ltd. was founded in 2011 and is headquartered in Toronto, Canada.
How the Company Makes MoneyDentalcorp Holdings generates revenue primarily through the acquisition and management of dental practices. The company earns money by partnering with dental clinics, where it acquires a stake in the practice and provides operational support to improve efficiency and profitability. Revenue is generated from dental services provided at these practices, including routine check-ups, orthodontics, and specialized dental procedures. Additionally, Dentalcorp benefits from economies of scale, centralized procurement, and marketing, which enhance the financial performance of its partner practices. The company may also engage in partnerships with dental supply companies and other healthcare providers to further optimize its operations and expand its service offerings.

dentalcorp Holdings Earnings Call Summary

Earnings Call Date:Aug 08, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong financial performance with significant growth in revenue, EBITDA, and free cash flow conversion. Strategic acquisitions and partnerships, particularly in AI technology, bolster future growth prospects. However, there are potential challenges with the continued rollout of the CDCP and interest rate expenses. Overall, the sentiment is positive due to the outweighing highlights.
Q3-2024 Updates
Positive Updates
Strong Revenue and EBITDA Growth
Revenue for Q3 2024 was $375.4 million, up 11.4% from Q3 2023. Adjusted EBITDA was $68.9 million, an increase of 13.1% over the same period.
Improved Free Cash Flow Conversion
Free cash flow conversion improved to 63% on an LTM basis, up from 58% in Q3 2023.
Successful M&A Activity
Acquired 4 practices for $16 million, expected to generate $2.3 million in pro forma adjusted EBITDA. Completed 9 acquisitions post-quarter-end, reaching the annual target of $20 million in acquired EBITDA.
Strategic Partnerships and Innovations
Formed a strategic partnership with VideaHealth to deploy AI technology across the network, enhancing clinical excellence and business efficiencies.
Deleveraging Efforts
Net leverage reduced to 4.0x, down 0.4x from the previous year, marking the fourth consecutive quarter of deleveraging.
Positive Outlook for Q4 2024
Anticipated revenue growth of 8% to 10% over Q4 2023, with adjusted EBITDA margins expected to increase by 20 basis points.
Negative Updates
Potential Disruption from CDCP Rollout
Uncertainty regarding the timing of the CDCP expansion to 18-64 age group could cause disruptions similar to the initial rollout in early 2024.
Interest Rate Challenges
Interest rate ceiling of 6% through January 2028, though improved from 6.6%, still represents a significant expense.
Company Guidance
During the Dentalcorp Q3 2024 earnings call, the company provided guidance indicating a robust financial performance with several key metrics. Dentalcorp reported a revenue of $375.4 million for the third quarter, marking an 11.4% increase from the same period in 2023. Adjusted EBITDA rose to $68.9 million, reflecting a 13.1% growth, while EBITDA margins improved by 30 basis points to 18.4%. The company also highlighted a same practice revenue growth of 4.2% for the quarter and achieved a free cash flow per share of $0.19, up by 36.4% year-over-year. They completed acquisitions adding $8.5 million in pro forma adjusted EBITDA after rent, bringing them close to their annual target of $20 million. Looking forward, Dentalcorp expects an 8% to 10% revenue increase in Q4 2024, with adjusted EBITDA margins projected to rise by 20 basis points compared to Q4 2023. Additionally, free cash flow conversion improved to 63% on an LTM basis, up from 58% in Q3 2023, with net leverage reduced to 4.0x, continuing a trend of deleveraging for the fourth consecutive quarter.

dentalcorp Holdings Financial Statement Overview

Summary
dentalcorp Holdings is experiencing steady revenue growth and has a solid cash flow position, which are positive indicators for future performance. However, the company faces challenges in profitability, as evidenced by negative net income and return on equity. The balance sheet is stable, with a manageable level of debt. To improve its financial standing, the company should focus on enhancing profitability while maintaining its growth trajectory.
Income Statement
65
Positive
dentalcorp Holdings has shown a consistent revenue growth trend, with a TTM revenue growth rate of 2.24%. However, the company is struggling with profitability, as indicated by a negative net profit margin of -3.66% and a modest EBIT margin of 1.12%. The gross profit margin is relatively healthy at 46.28%, suggesting efficient cost management. Overall, while revenue is growing, the company needs to improve its profitability metrics.
Balance Sheet
60
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.78, indicating a balanced approach to leveraging. However, the return on equity is negative at -3.31%, reflecting challenges in generating returns for shareholders. The equity ratio stands at 51.63%, suggesting a stable capital structure. The company needs to focus on improving its profitability to enhance shareholder value.
Cash Flow
70
Positive
The cash flow statement reflects a positive trajectory, with a free cash flow growth rate of 9.06% in the TTM period. The operating cash flow to net income ratio is slightly above 1, indicating that the company generates sufficient cash from operations to cover its net losses. The free cash flow to net income ratio is 0.74, showing that while the company is not yet profitable, it is generating positive cash flows, which is a positive sign for future financial health.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.62B1.55B1.43B1.25B1.03B666.20M
Gross Profit809.20M772.70M493.70M611.90M495.40M321.60M
EBITDA234.80M222.20M197.40M183.40M75.10M99.70M
Net Income-45.10M-59.40M-85.60M-16.60M-160.40M-157.10M
Balance Sheet
Total Assets3.43B3.38B3.29B3.38B2.84B2.57B
Cash, Cash Equivalents and Short-Term Investments77.70M79.50M39.00M110.50M141.80M101.50M
Total Debt1.39B1.37B1.35B1.37B1.15B1.65B
Total Liabilities1.66B1.61B1.55B1.59B1.32B1.99B
Stockholders Equity1.77B1.77B1.74B1.79B1.51B584.00M
Cash Flow
Free Cash Flow167.30M147.10M123.80M106.00M36.80M-52.40M
Operating Cash Flow220.20M194.20M153.40M138.60M55.10M-35.20M
Investing Cash Flow-228.00M-170.80M-172.10M-419.80M-262.90M-151.30M
Financing Cash Flow13.20M16.50M-52.30M247.50M248.10M202.60M

dentalcorp Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price10.86
Price Trends
50DMA
8.26
Positive
100DMA
8.36
Positive
200DMA
8.13
Positive
Market Momentum
MACD
0.41
Negative
RSI
85.69
Negative
STOCH
77.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DNTL, the sentiment is Positive. The current price of 10.86 is above the 20-day moving average (MA) of 8.50, above the 50-day MA of 8.26, and above the 200-day MA of 8.13, indicating a bullish trend. The MACD of 0.41 indicates Negative momentum. The RSI at 85.69 is Negative, neither overbought nor oversold. The STOCH value of 77.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DNTL.

dentalcorp Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
C$1.27B15.3455.86%3.37%8.68%39.93%
61
Neutral
C$2.16B-2.58%0.46%9.94%35.48%
59
Neutral
C$266.54M2.06105.57%2.50%-35.35%948.72%
59
Neutral
C$1.73B46.945.55%5.00%10.13%1.30%
53
Neutral
C$220.68M-118.58-2.09%0.57%-0.16%75.25%
46
Neutral
C$1.31B-9.99-15.57%20.36%-186.10%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DNTL
dentalcorp Holdings
10.86
2.47
29.44%
TSE:CRRX
CareRx
3.62
1.61
80.10%
TSE:EXE
Extendicare
14.87
5.80
63.95%
TSE:SIA
Sienna Senior Living
18.72
2.92
18.48%
TSE:DR
Medical Facilities
14.14
1.13
8.69%
TSE:WELL
WELL Health Technologies Corp
5.14
0.74
16.82%

dentalcorp Holdings Corporate Events

Business Operations and StrategyFinancial Disclosures
Dentalcorp Holdings Reports Strong Q2 2025 Financial Results and Expansion
Positive
Aug 8, 2025

Dentalcorp Holdings reported strong financial results for the second quarter of 2025, with revenue increasing by 8.9% to $435.2 million and Adjusted EBITDA growing by 9.9% to $81.2 million compared to the same period in 2024. The company also expanded its national presence by acquiring eight new practice locations, contributing to a record Adjusted Free Cash Flow of $45.6 million and a decrease in net debt ratio, indicating robust operational performance and strategic growth.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$13.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Business Operations and Strategy
Dentalcorp to Present at Key Investor Conferences in September 2025
Positive
Jul 14, 2025

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, announced its participation in several upcoming investor conferences in September 2025. These events, including the Morgan Stanley Global Healthcare Conference and the Jefferies Healthcare Services Conference, provide an opportunity for Dentalcorp to showcase its growth and strategic initiatives, potentially enhancing its industry positioning and stakeholder engagement.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

DividendsFinancial Disclosures
Dentalcorp Declares Dividend and Schedules Q2 2025 Results Release
Neutral
Jun 20, 2025

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, has declared a dividend of $0.025 per share, payable on July 22, 2025, to shareholders of record as of July 3, 2025. The company also announced that it will release its second-quarter 2025 financial results on August 8, 2025, followed by a conference call to provide a business update, which may influence stakeholder perceptions and market positioning.

The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 21, 2025